Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis.

[1]  H. Parving,et al.  Vitamin D Levels and Mortality in Type 2 Diabetes , 2010, Diabetes Care.

[2]  H. Parving,et al.  VITAMIN D LEVELS AND MORTALITY IN TYPE 2 DIABETES: PP.17.143 , 2010 .

[3]  R. Berg,et al.  A Systematic Review and Meta-analysis , 2010 .

[4]  M. Siavash,et al.  Calcium and Vitamin D Status in Heart Failure Patients in Isfahan, Iran , 2010, Biological Trace Element Research.

[5]  A. Silman,et al.  Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. , 2009, European journal of endocrinology.

[6]  E. Barrett-Connor,et al.  Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. , 2009, Atherosclerosis.

[7]  G. Nijpels,et al.  Vitamin D and mortality in older men and women , 2009, Clinical endocrinology.

[8]  Keith C. Norris,et al.  Chronic kidney disease, hypovitaminosis D, and mortality in the United States. , 2009, Kidney international.

[9]  Markku Heliövaara,et al.  American Journal of Epidemiology Original Contribution Vitamin D Status and the Risk of Cardiovascular Disease Death , 2022 .

[10]  Carlos A Camargo,et al.  Prospective Study of Serum 25‐Hydroxyvitamin D Level, Cardiovascular Disease Mortality, and All‐Cause Mortality in Older U.S. Adults , 2009, Journal of the American Geriatrics Society.

[11]  K. Maki,et al.  Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. , 2009, Journal of clinical lipidology.

[12]  M. McCullough,et al.  Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. , 2009, Annual review of nutrition.

[13]  M. Chonchol,et al.  25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. , 2009, Atherosclerosis.

[14]  G. Tenderich,et al.  Circulating calcitriol concentrations and total mortality. , 2009, Clinical chemistry.

[15]  R. Konwar,et al.  Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. , 2009, Indian journal of medical sciences.

[16]  O. Franco,et al.  Plasma 25-Hydroxyvitamin D Concentration and Metabolic Syndrome Among Middle-Aged and Elderly Chinese Individuals , 2009, Diabetes Care.

[17]  A. Varasteh,et al.  Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients. , 2009, Saudi medical journal.

[18]  J. O’Keefe,et al.  Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? , 2008, Journal of the American College of Cardiology.

[19]  D. V. von Mühlen,et al.  Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. , 2008, The American journal of clinical nutrition.

[20]  D. Whellan,et al.  Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). , 2008, The American journal of cardiology.

[21]  S. Browning,et al.  Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  W. März,et al.  Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. , 2008, The Journal of clinical endocrinology and metabolism.

[23]  S. Penckofer,et al.  The “Sunshine Deficit” and Cardiovascular Disease , 2008, Circulation.

[24]  A. Reunanen,et al.  Serum Vitamin D and Subsequent Occurrence of Type 2 Diabetes , 2008, Epidemiology.

[25]  W. März,et al.  Low Vitamin D Levels Predict Stroke in Patients Referred to Coronary Angiography , 2008, Stroke.

[26]  B. Astor,et al.  25-hydroxyvitamin D levels and the risk of mortality in the general population. , 2008, Archives of internal medicine.

[27]  D. V. von Mühlen,et al.  Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. , 2008, European journal of endocrinology.

[28]  N. Wareham,et al.  Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance , 2008, Diabetes.

[29]  Stefan Pilz,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[30]  E. Rimm,et al.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. , 2008, Archives of internal medicine.

[31]  P. Raggi,et al.  Serum 25-Hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001 to 2004 , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[32]  L. Carbone,et al.  Hypovitaminosis D in African Americans Residing in Memphis, Tennessee With and Without Heart Failure , 2008, The American journal of the medical sciences.

[33]  S. Grundy.  A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor , 2008 .

[34]  J. Després,et al.  From individual risk factors and the metabolic syndrome to global cardiometabolic risk , 2008 .

[35]  D. Mauricio,et al.  Role of vitamin D in the pathogenesis of type 2 diabetes mellitus , 2008, Diabetes, obesity & metabolism.

[36]  A. Kenny,et al.  The Association Between Vitamin D and Inflammation with the 6‐Minute Walk and Frailty in Patients with Heart Failure , 2008, Journal of the American Geriatrics Society.

[37]  R. Cumming,et al.  Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality , 2008, Clinical endocrinology.

[38]  E. Hyppönen,et al.  25-Hydroxyvitamin D, IGF-1, and Metabolic Syndrome at 45 Years of Age , 2008, Diabetes.

[39]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[40]  S. Poppitt,et al.  Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity , 2008, Nutrition Journal.

[41]  J. Vidal,et al.  Vitamin D, PTH, and the Metabolic Syndrome in Severely Obese Subjects , 2008, Obesity surgery.

[42]  M. Chonchol,et al.  Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[43]  G. Guaraldi,et al.  Association of serum vitamin D levels nd type 2 diabetes in HIV infection in the Modena cohort , 2008 .

[44]  D. V. von Mühlen,et al.  Vitamin D, Parathyroid Hormone Levels, and the Prevalence of Metabolic Syndrome in Community-Dwelling Older Adults , 2007, Diabetes Care.

[45]  H. Escobar-Morreale,et al.  Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. , 2007, Clinical nutrition.

[46]  Sara Gandini,et al.  Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[47]  Paul N. Smith,et al.  Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures. , 2007, Annals of clinical and laboratory science.

[48]  Keith C. Norris,et al.  Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. , 2007, Archives of internal medicine.

[49]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[50]  G. Riedmüller,et al.  Serum concentrations of vitamin D are significant and independent predictors of mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study , 2007 .

[51]  F. Hu,et al.  REVIEW: The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis , 2007 .

[52]  A. Reunanen,et al.  Serum vitamin D and occurrence of subsequent type 2 diabetes: a pooled analysis of two Finnish cohorts [abstract] , 2007 .

[53]  L. Carbone,et al.  Micronutrients in African-Americans with decompensated and compensated heart failure. , 2006, Translational research : the journal of laboratory and clinical medicine.

[54]  G. Targher,et al.  Serum 25‐hydroxyvitamin D3 concentrations and carotid artery intima‐media thickness among type 2 diabetic patients , 2006, Clinical endocrinology.

[55]  M. Itoh,et al.  Hypovitaminosis D in type 2 diabetes mellitus: Association with microvascular complications and type of treatment. , 2006, Endocrine journal.

[56]  J. Breslow.  n-3 fatty acids and cardiovascular disease. , 2006, The American journal of clinical nutrition.

[57]  M. Fisher.  Cardiometabolic disease: the new challenge? , 2006 .

[58]  G. Targher,et al.  Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. , 2006, Diabetes care.

[59]  B. Boucher.  Hypovitaminosis D and risk of Type 2 diabetes in British South Asians , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[60]  E. Warburton,et al.  Reduced Vitamin D in Acute Stroke , 2006, Stroke.

[61]  R. Koerfer,et al.  Putting cardiovascular disease and vitamin D insufficiency into perspective , 2005, British Journal of Nutrition.

[62]  T. Rönnemaa,et al.  Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. , 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[63]  E. Ford,et al.  Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. , 2005, Diabetes care.

[64]  B. Boucher,et al.  Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. , 2004, The American journal of clinical nutrition.

[65]  Yan Zhu,et al.  Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. , 2004, The American journal of clinical nutrition.

[66]  M. Sowers,et al.  Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. , 2004, Diabetes care.

[67]  Julian P T Higgins,et al.  Controlling the risk of spurious findings from meta‐regression , 2004, Statistics in medicine.

[68]  M. Saad,et al.  Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .

[69]  C. Hales,et al.  Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians , 1995, Diabetologia.

[70]  P. Sarma,et al.  Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease , 2004, European Journal of Epidemiology.

[71]  E. Rimm,et al.  A prospective study of calcium intake from diet and supplements and risk of ischemic heart disease among men. , 2003, The American journal of clinical nutrition.

[72]  M. Holick,et al.  Vitamin D insufficiency among free-living healthy young adults. , 2002, The American journal of medicine.

[73]  Reiko Ohmori,et al.  asociations of plasma vitamin D and Osteopotin levels with coronary artery calcification , 2002 .

[74]  Judea Pearl,et al.  Direct and Indirect Effects , 2001, UAI.

[75]  M. Holick,et al.  25-hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue , 2001, The Lancet.

[76]  J. Flanagan,et al.  25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. , 2001, Lancet.

[77]  P. Malloy,et al.  Vitamin D resistance. , 1999, The American journal of medicine.

[78]  T. Sellers,et al.  Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. , 1999, American journal of epidemiology.

[79]  P. Glasziou,et al.  Bias in meta-analysis detected by a simple, graphical test. Graphical test is itself biased. , 1998, BMJ.

[80]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[81]  E. Feskens,et al.  Vitamin D, glucose tolerance and insulinaemia in elderly men , 1997, Diabetologia.

[82]  P. Metcalf,et al.  Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. , 1995, Diabetes research and clinical practice.

[83]  M. Hewison,et al.  Vitamin D resistance , 1994 .

[84]  N. Golden,et al.  in Women with , 1992 .

[85]  R. Beaglehole,et al.  Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. , 1990, International journal of epidemiology.

[86]  M. Holick,et al.  AGE, VITAMIN D, AND SOLAR ULTRAVIOLET , 1989, The Lancet.

[87]  F. Kokot,et al.  [Serum levels of calcitonin, parathyroid hormone and 25-hydroxycholecalciferol in patients with diabetes mellitus]. , 1989, Endokrynologia Polska.

[88]  Merzon Ka,et al.  [Plasma 25-hydroxyvitamin D3 level in patients with chronic cardiac insufficiency]. , 1988 .

[89]  P. Geusens,et al.  Mineral Metabolism and Bone Mass at Peripheral and Axial Skeleton in Diabetes Mellitus , 1988, Diabetes.

[90]  K. Merzon,et al.  [Plasma 25-hydroxyvitamin D3 level in patients with chronic cardiac insufficiency]. , 1988, Kardiologiia.

[91]  R. Simpson,et al.  Involvement of vitamin D3 with cardiovascular function. II. Direct and indirect effects. , 1987, The American journal of physiology.

[92]  M. Holick,et al.  Aging decreases the capacity of human skin to produce vitamin D3. , 1985, The Journal of clinical investigation.

[93]  D. Zeeuw,et al.  CAPTOPRIL AND THE IMMUNE SYSTEM , 1981, The Lancet.

[94]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[95]  B. Lund,et al.  Vitamin D and Ischaemic Heart Disease , 1978, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[96]  H. Schmidt‐Gayk,et al.  Serum 25-hydroxycalciferol in myocardial infarction. , 1977, Atherosclerosis.

[97]  M. Haussler,et al.  Diabetes and vitamin D metabolism , 1976 .

[98]  L. Rosenberg.  Vitamin-responsive inherited metabolic disorders. , 1976, Advances in human genetics.

[99]  M. Seelig.  Letter: Ischaemic heart disease, vitamins D and A, and magnesium. , 1975, British medical journal.

[100]  F. Eskin.  Letter: Vitamin D and myocardial infarction. , 1974, British medical journal.

[101]  V. Lindén.  Vitamin D and Myocardial Infarction , 1974, British medical journal.

[102]  L. Dalderup.  Ischaemic heart-disease and vitamin D. , 1973, Lancet.

[103]  H. Taussig.  Possible injury to the cardiovascular system from vitamin D. , 1966, Annals of internal medicine.

[104]  A. Beuren,et al.  [Vitamin D-hypercalcemia cardiovascular disease]. , 1966, Deutsche medizinische Wochenschrift.

[105]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.